MedTrace Logo

Effects of Soluble Phosphate in Humans

NCT02095392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2015-12-02

No results posted yet for this study

Summary

The study was conducted to investigate the effect of soluble phosphate in combination with different calcium doses on calcium and phosphorus metabolism and further physiological parameters in healthy subjects. The main aim of the study is to investigate the influence of a soluble phosphate supplementation on the fasting blood phosphate concentration and the dependency of an additional calcium intake.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

P1000/Ca0

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1g phosphorus/d\]

DIETARY_SUPPLEMENT

P1000/Ca500

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[0,5 g calcium\]

DIETARY_SUPPLEMENT

P1000/Ca1000

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[1 g calcium\]

DIETARY_SUPPLEMENT

Placebo

all participants consume two weeks before intervention the beverage without phosphate and calcium

Sponsors & Collaborators

  • University of Jena

    lead OTHER

Principal Investigators

  • Michael Glei, Prof. Dr. · Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02095392 on ClinicalTrials.gov